These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12032108)

  • 41. Drug titration patterns and HbA 1c levels in type 2 diabetes.
    Maclean JR; Chapman RH; Ferrufino CP; Krishnarajah G
    Int J Clin Pract; 2009 Jul; 63(7):1008-16. PubMed ID: 19570118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.
    Petitti DB; Klingensmith GJ; Bell RA; Andrews JS; Dabelea D; Imperatore G; Marcovina S; Pihoker C; Standiford D; Waitzfelder B; Mayer-Davis E;
    J Pediatr; 2009 Nov; 155(5):668-72.e1-3. PubMed ID: 19643434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
    Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
    Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medication adherence and racial differences in A1C control.
    Adams AS; Trinacty CM; Zhang F; Kleinman K; Grant RW; Meigs JB; Soumerai SB; Ross-Degnan D
    Diabetes Care; 2008 May; 31(5):916-21. PubMed ID: 18235050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Distress Reduction on Behavioral Correlates and A1C in African American Women with Uncontrolled Type 2 Diabetes: Results from EMPOWER.
    Cummings DM; Lutes LD; Littlewood K; Solar C; Hambidge B; Gatlin P
    Ethn Dis; 2017; 27(2):155-160. PubMed ID: 28439186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
    Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
    Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
    Salvo MC; Brooks AM
    Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
    Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.
    Odegard PS; Goo A; Hummel J; Williams KL; Gray SL
    Ann Pharmacother; 2005 Mar; 39(3):433-40. PubMed ID: 15701763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of community health worker-led diabetes medication decision-making support for low-income Latino and African American adults with diabetes using e-health tools versus print materials: a randomized, controlled trial.
    Heisler M; Choi H; Palmisano G; Mase R; Richardson C; Fagerlin A; Montori VM; Spencer M; An LC
    Ann Intern Med; 2014 Nov; 161(10 Suppl):S13-22. PubMed ID: 25402398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety profile of exenatide once weekly compared with insulin once daily in Japanese patients with type 2 diabetes treated with oral antidiabetes drug(s): results from a 26-week, randomized, open-label, parallel-group, multicenter, noninferiority study.
    Inagaki N; Atsumi Y; Oura T; Saito H; Imaoka T
    Clin Ther; 2012 Sep; 34(9):1892-908.e1. PubMed ID: 22884767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials.
    DeFronzo RA; Stonehouse AH; Han J; Wintle ME
    Diabet Med; 2010 Mar; 27(3):309-17. PubMed ID: 20536494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonadherence to insulin therapy in low-income, type 2 diabetic patients.
    Lerman I; Díaz JP; Ibarguengoitia ME; Pérez FJ; Villa AR; Velasco ML; Cruz RG; Rodrigo JA
    Endocr Pract; 2009; 15(1):41-6. PubMed ID: 19211396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short and long-term outcomes from a multisession diabetes education program targeting low-income minority patients: a six-month follow up.
    Ryan JG; Jennings T; Vittoria I; Fedders M
    Clin Ther; 2013 Jan; 35(1):A43-53. PubMed ID: 23328276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
    Guerci B; Drouin P; Grangé V; Bougnères P; Fontaine P; Kerlan V; Passa P; Thivolet Ch; Vialettes B; Charbonnel B;
    Diabetes Metab; 2003 Dec; 29(6):587-94. PubMed ID: 14707887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.
    Lewin A; Lipetz R; Wu J; Schwartz S
    Clin Ther; 2007 May; 29(5):844-855. PubMed ID: 17697903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitus.
    Esposito K; Maiorino MI; Di Palo C; Giugliano D;
    Diabet Med; 2009 Sep; 26(9):900-7. PubMed ID: 19719711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.